1. Home
  2. RYTM vs SEZL Comparison

RYTM vs SEZL Comparison

Compare RYTM & SEZL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • SEZL
  • Stock Information
  • Founded
  • RYTM 2008
  • SEZL 2016
  • Country
  • RYTM United States
  • SEZL United States
  • Employees
  • RYTM N/A
  • SEZL N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • SEZL Diversified Financial Services
  • Sector
  • RYTM Health Care
  • SEZL Finance
  • Exchange
  • RYTM Nasdaq
  • SEZL Nasdaq
  • Market Cap
  • RYTM 5.9B
  • SEZL 5.0B
  • IPO Year
  • RYTM 2017
  • SEZL N/A
  • Fundamental
  • Price
  • RYTM $97.61
  • SEZL $91.87
  • Analyst Decision
  • RYTM Strong Buy
  • SEZL Strong Buy
  • Analyst Count
  • RYTM 13
  • SEZL 3
  • Target Price
  • RYTM $101.92
  • SEZL $124.33
  • AVG Volume (30 Days)
  • RYTM 578.8K
  • SEZL 1.3M
  • Earning Date
  • RYTM 08-05-2025
  • SEZL 08-07-2025
  • Dividend Yield
  • RYTM N/A
  • SEZL N/A
  • EPS Growth
  • RYTM N/A
  • SEZL 146.46
  • EPS
  • RYTM N/A
  • SEZL 2.93
  • Revenue
  • RYTM $156,287,000.00
  • SEZL $371,794,890.00
  • Revenue This Year
  • RYTM $37.86
  • SEZL $66.19
  • Revenue Next Year
  • RYTM $72.72
  • SEZL $25.26
  • P/E Ratio
  • RYTM N/A
  • SEZL $31.31
  • Revenue Growth
  • RYTM 53.55
  • SEZL 92.95
  • 52 Week Low
  • RYTM $43.57
  • SEZL $19.67
  • 52 Week High
  • RYTM $99.04
  • SEZL $186.74
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 73.48
  • SEZL 31.48
  • Support Level
  • RYTM $95.30
  • SEZL $87.60
  • Resistance Level
  • RYTM $99.04
  • SEZL $94.83
  • Average True Range (ATR)
  • RYTM 3.21
  • SEZL 10.90
  • MACD
  • RYTM 0.20
  • SEZL -6.15
  • Stochastic Oscillator
  • RYTM 90.50
  • SEZL 10.86

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About SEZL Sezzle Inc.

Sezzle Inc is a financing institution that offers technology-driven payment platform. It allows customers to split their purchase into four installments and pay over 6 weeks with only the first payment due at the time of purchase. Companies operations comprise one reportable segment, the majority of which derives revenue from payment processing platform in North America.

Share on Social Networks: